Skip to content
The Nexus
DossierENTITY

Nate Fernhoff

Coverage of Nate Fernhoff in the Nexus archive.

Earliest in view: Jul 1 · 11:38 UTCMost recent: Jul 1 · 11:38 UTC
Co-mentioned in this coverage
FDAorganization1Orca Bioorganization1Tregziproduct1blood cancertopic1graft-versus-host diseasetopic1stem cell transplanttopic1
Recent coverage
  • HEALTHJul 1 · 11:38 UTCSTAT NEWS
    STAT+: FDA approves Orca Bio’s T cell therapy for blood cancer patients

    The FDA approved Orca Bio's T cell therapy, Tregzi, which reduces immune reaction risks for blood cancer patients undergoing stem cell transplants. The therapy offers a curative alternative to traditional transplants that carry high risks of chronic graft-versus-host disease.

Nate Fernhoff · Dossier · The Nexus